Neuralink's Ambitious Trials and Neurotechnology's Future

This chapter details Neuralink's intention to start clinical trials for brain implant chips in Great Britain by 2025, aimed at aiding those with severe neurological disabilities. It also delves into the ethical issues, regulatory challenges, and competitive landscape in the neurotechnology sector as the company moves towards global testing and expanded medical uses.